Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / EGFR 돌연변이 NSCLC 환자 유래 오가노이드에서 표적 치료법에 대한 민감도…
JoVE Journal
Cancer Research

This content is Free Access.

JoVE Journal Cancer Research
EGFR 돌연변이 NSCLC 환자 유래 오가노이드에서 표적 치료법에 대한 민감도 프로파일링
Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
Journal (Cancer Research)
Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
Lentiviral Infection of MPNST Cells and Genomic DNA Isolation for Genome-Scale shRNA Screens (Video) | JoVE
Journal (Cancer Research)
Lentiviral Infection of MPNST Cells and Genomic DNA Isolation for Genome-Scale shRNA Screens (Video) | JoVE
 
Click here for the English version

EGFR 돌연변이 NSCLC 환자 유래 오가노이드에서 표적 치료법에 대한 민감도 프로파일링

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

이 프로토콜은 NSCLC 환자 유래 오가노이드 모델에서 표적화된 신호전달 억제제에 대한 약물 민감성의 표준화된 평가를 기술한다.

Tags

암 연구 문제 177 오가노이드 폐 오가노이드 PDO NSCLC 폐암 오시머티닙 EGFR 표적 억제제 내성
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter